Bruno Poddevin

1.1k total citations
10 papers, 955 citations indexed

About

Bruno Poddevin is a scholar working on Biotechnology, Immunology and Molecular Biology. According to data from OpenAlex, Bruno Poddevin has authored 10 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biotechnology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Bruno Poddevin's work include Microbial Inactivation Methods (6 papers), Toxin Mechanisms and Immunotoxins (6 papers) and Transgenic Plants and Applications (3 papers). Bruno Poddevin is often cited by papers focused on Microbial Inactivation Methods (6 papers), Toxin Mechanisms and Immunotoxins (6 papers) and Transgenic Plants and Applications (3 papers). Bruno Poddevin collaborates with scholars based in France and United States. Bruno Poddevin's co-authors include Stéphane Orlowski, Lluis M. Mir, Jean Belehradek, Claude Paoletti, LM Mir, C. Domenge, G Schwaab, B Luboïnski, Yves Pommier and Jean‐François Riou and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Biochimica et Biophysica Acta (BBA) - Biomembranes and Biochemical Pharmacology.

In The Last Decade

Bruno Poddevin

10 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Poddevin France 10 704 484 325 265 72 10 955
LM Mir France 7 789 1.1× 521 1.1× 324 1.0× 141 0.5× 48 0.7× 9 853
Sophie Sixou France 12 168 0.2× 125 0.3× 49 0.2× 325 1.2× 75 1.0× 26 582
O. A. Koval Russia 16 55 0.1× 67 0.1× 131 0.4× 458 1.7× 186 2.6× 77 827
Emily H. Hall United States 13 141 0.2× 74 0.2× 147 0.5× 265 1.0× 110 1.5× 18 519
Günter A. Hofmann United States 11 253 0.4× 122 0.3× 85 0.3× 130 0.5× 11 0.2× 20 516
Betsy L. Lytle United States 16 178 0.3× 235 0.5× 82 0.3× 528 2.0× 81 1.1× 19 837
Tanja Dolinšek Slovenia 15 283 0.4× 135 0.3× 91 0.3× 190 0.7× 53 0.7× 15 399
Sung-Hwan You South Korea 12 350 0.5× 312 0.6× 78 0.2× 169 0.6× 76 1.1× 20 588
C. Nicolau United States 14 106 0.2× 77 0.2× 58 0.2× 388 1.5× 43 0.6× 47 665
Nuno Bernardes Portugal 14 205 0.3× 129 0.3× 85 0.3× 463 1.7× 73 1.0× 26 820

Countries citing papers authored by Bruno Poddevin

Since Specialization
Citations

This map shows the geographic impact of Bruno Poddevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Poddevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Poddevin more than expected).

Fields of papers citing papers by Bruno Poddevin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Poddevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Poddevin. The network helps show where Bruno Poddevin may publish in the future.

Co-authorship network of co-authors of Bruno Poddevin

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Poddevin. A scholar is included among the top collaborators of Bruno Poddevin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Poddevin. Bruno Poddevin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Orlowski, Stéphane, et al.. (1999). Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. Biochemical Pharmacology. 57(1). 45–56. 104 indexed citations
2.
3.
Orlowski, Stéphane, et al.. (1994). Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1190(1). 155–163. 120 indexed citations
4.
Pommier, Yves, Bruno Poddevin, Meenu Gupta, & Jennifer Jenkins. (1994). DNA Topoisomerases I and II Cleavage Sites in the Type 1 Human Immunodeficiency Virus (HIV-1) DNA Promoter Region. Biochemical and Biophysical Research Communications. 205(3). 1601–1609. 11 indexed citations
5.
Poddevin, Bruno, Jean‐François Riou, François Lavelle, & Yves Pommier. (1993). Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.. Molecular Pharmacology. 44(4). 767–774. 67 indexed citations
6.
Mir, LM, et al.. (1992). Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses.. PubMed. 3(3). 331–4. 87 indexed citations
7.
Belehradek, Jean, Stéphane Orlowski, Bruno Poddevin, Claude Paoletti, & Lluis M. Mir. (1991). Electrochemotherapy of spontaneous mammary tumours in mice. European Journal of Cancer and Clinical Oncology. 27(1). 73–76. 138 indexed citations
8.
Poddevin, Bruno, Stéphane Orlowski, Jean Belehradek, & Lluis M. Mir. (1991). Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochemical Pharmacology. 42. S67–S75. 182 indexed citations
9.
Mir, LM, C. Domenge, Stéphane Orlowski, et al.. (1991). [Electrochemotherapy, a new antitumor treatment: first clinical trial].. PubMed. 313(13). 613–8. 207 indexed citations
10.
Poddevin, Bruno, Jean Belehradek, & Lluis M. Mir. (1990). Stable [57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrations. Biochemical and Biophysical Research Communications. 173(1). 259–264. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by LM Mir Breakdown of academic impact, for papers by Sophie Sixou Breakdown of academic impact, for papers by O. A. Koval Breakdown of academic impact, for papers by Emily H. Hall Breakdown of academic impact, for papers by Günter A. Hofmann Breakdown of academic impact, for papers by Betsy L. Lytle Breakdown of academic impact, for papers by Tanja Dolinšek Breakdown of academic impact, for papers by Sung-Hwan You Breakdown of academic impact, for papers by C. Nicolau Breakdown of academic impact, for papers by Nuno Bernardes
Rankless by CCL
2026